NCT00372931已完成2 期
A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 120
- 试验地点
- 2
- 主要终点
- Mean IOP change from baseline
研究概览
简要总结
The purpose of this study is to determine whether AL-37807 is safe and effective in treating patients with open-angle glaucoma or ocular hypertension
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients of either sex and any race with open-angle glaucoma or ocular hypertension; logMAR visual acuity not worse than 0.60; additionally clinically relevant ophthalmic or systemic conditions may be excluded
排除标准
- 未提供
结局指标
主要结局
Mean IOP change from baseline
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
终止
1 期
Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP LossAdvanced Solid TumorsLymphomaNCT03435250Institut de Recherches Internationales Servier123
终止
1 期
Single Ascending Dose Trial in Patients With Type 2 DiabetesDiabetes MellitusNCT01492465Amgen47
已完成
2 期
Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell CarcinomaKidney NeoplasmsNCT00076011Pfizer52
已完成
3 期
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular HypertensionNCT00293787Alcon Research156
已完成
1 期
Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827PsoriasisNCT00867100Bausch Health Americas, Inc.84